Federal Health Officials Allowed a Prevention Grant to Expire on September 30

Federal health officials allowed a prevention grant to expire on September 30, eliminating $29.2 million for community-based organizations that test thousands of Texans for HIV. The Texas Tribune reported that Texas was the nation’s largest beneficiary of the funding program known as PS21-2102, which supported 11 community-based organizations, mostly in urban areas, over the past five years.

Key Clinical Takeaways:
• The Centers for Disease Control and Prevention allowed the PS21-2102 grant to expire on September 30, cutting $29.2 million in community-level HIV testing funds in Texas.
• Community-based organizations achieved a new diagnosis rate three times higher than local health departments between 2012 and 2017.
• State health departments received a one-time allocation of $5.2 million through May 2027, with only a fraction designated for community groups.

Loss of community-based testing networks

The expiring federal dollars covered HIV test costs, linked patients to care, and paid for prophylaxis medications that nearly eliminate infection risks. Without these resources, organizations have been forced to pare back services or scramble for alternate funds, according to The Texas Tribune. The Centers for Disease Control and Prevention did not respond to a request for comment regarding the expiration.

“The front line in the testing portion of it really are the community-based organizations — they’re the ones that are in their community,” said Philip Keiser, a professor at the University of Texas Medical Branch who studies HIV.

Rolled out in 2021, the PS21-2102 initiative distributed $239 million nationwide. Its elimination aligns with a broader federal offensive targeting HIV-eradication efforts under President Donald Trump’s administration, according to Philip Huang, director of Dallas County Health and Human Services and vice chair of the state’s Public Health Funding and Policy Committee.

Beyond HIV prevention, federal cuts have slashed pandemic-era grants supporting immunization programs, laboratory capacity, and infectious disease outbreak investigations in Texas.

Federal award addresses funding shortfall through 2027

To address the shortfall, federal authorities issued a one-time award of over $5.2 million to the Texas Department of State Health Services, running through May 2027. DSHS spokesperson Lara Anton stated in an email reported by The Texas Tribune that approximately $1.2 million of that award will flow to community-based organizations, while remaining funds support other state surveillance and prevention efforts.

State health agencies are encouraged but not required to allocate 10 percent of those funds to community groups, leaving advocates concerned that resources will concentrate in traditional clinical settings.

In Houston, Allies in Hope received about $441,000 annually from the expired grant, covering outreach, a mobile unit, and over a quarter of its 2,000 yearly tests. CEO William Jeffrey Campbell told The Texas Tribune that unless the organization finds new sources of funding, it will have to reduce testing.

State lawmakers are weighing replacement funds for the upcoming legislative session, according to state Representative Venton Jones, a Dallas Democrat and the first openly HIV-positive lawmaker in the Texas Legislature. Jones vowed to pursue state-level solutions while maintaining that federal restoration is necessary.

“This is a huge hit to our ability to respond to the epidemic,” Jones said. “Ultimately, we want to make sure that those funds are put back by the federal government, by the CDC, because those are critical.”

Outreach efficiency versus clinical care

Texas ranks fifth nationwide for new HIV diagnoses per capita, based on 2024 data from AIDSVu, a mapping tool developed at Emory University in partnership with Gilead Sciences. While Keiser said that both clinics and community organizations form vital prevention components, shifting resources away from community groups resembles “robbing Peter to pay Paul.”

Community organizations often operate in non-traditional venues like bars and nightclubs, effectively reaching vulnerable populations who might avoid formal medical clinics due to social stigma or privacy concerns. Historical data from 2012 to 2017 show community-based organizations diagnosed a new HIV case in 1.4 percent of CDC-funded tests, compared with 0.5 percent for tests administered by local health departments.

“There’s a lot of stigma in the community, and they don’t want people to know their sexuality,” Emma Sinnott, vice president of health center operations at Vivent Health in Austin, told The Texas Tribune. “Outreach allows access, testing and meeting people where they’re at.”

Vivent Health utilized its PS21-2102 award to fund outreach testing and awareness, covering 30 percent of its prevention budget. Sinnott said that while larger organizations can temporarily absorb the shock, the cuts will eventually restrict outreach events and limit access to newer post-exposure prophylaxis medications, such as injectables.

Long-term economic impacts of screening cuts

Experts emphasize that screening investments yield substantial economic returns, given that a single lifetime HIV treatment cost can reach up to $1 million, according to Anthony Fojo, a medicine professor at Johns Hopkins Medicine. Running 1,000 tests to identify a single positive case prevents downstream transmissions and ultimately reduces overall healthcare expenditures.

In San Antonio, Black Efforts Against the Threat of AIDS relied on the federal grant to cover 20 percent of its 5,000 annual tests. Executive Director Michele Durham said that reduced testing capacity leaves more individuals unaware of their status, heightening community transmission risks.

“For us to let up off the gas right now is just not our smartest move as a community and as a nation,” Durham said.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.